Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Chinese Journal of Integrative Medicine

22-02-2024 | Original Article

Tongxinluo Activates PI3K/AKT Signaling Pathway to Inhibit Endothelial Mesenchymal Transition and Attenuate Myocardial Fibrosis after Ischemia-Reperfusion in Mice

Authors: Ya-ru Wei, Yun-long Hou, Yu-jie Yin, Zhen Li, Yi Liu, Ning-xin Han, Zi-xuan Wang, Lu Liu, Xiao-qi Wang, Yuan-jie Hao, Kun Ma, Jiao-jiao Gu, Zhen-hua Jia

Published in: Chinese Journal of Integrative Medicine

Login to get access
Metadata
Title
Tongxinluo Activates PI3K/AKT Signaling Pathway to Inhibit Endothelial Mesenchymal Transition and Attenuate Myocardial Fibrosis after Ischemia-Reperfusion in Mice
Authors
Ya-ru Wei
Yun-long Hou
Yu-jie Yin
Zhen Li
Yi Liu
Ning-xin Han
Zi-xuan Wang
Lu Liu
Xiao-qi Wang
Yuan-jie Hao
Kun Ma
Jiao-jiao Gu
Zhen-hua Jia
Publication date
22-02-2024
Publisher
Springer Nature Singapore
Published in
Chinese Journal of Integrative Medicine
Print ISSN: 1672-0415
Electronic ISSN: 1993-0402
DOI
https://doi.org/10.1007/s11655-024-3652-5